Royalty Pharma plc【RPRX】Balance sheet

Market cap

$23.4B

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	1,009	1,541	1,711	477	929
Marketable securities, current	70	66	1	18	58
Total cash & short-term investments	1,079	1,607	1,712	495	987
Total current assets	2,697	2,878	2,555	1,274	1,802
Marketable securities, non-current	144	204	226	437	694
Total non-current assets	13,323	14,638	14,259	15,108	16,421
Total assets	16,020	17,516	16,813	16,382	18,223
Long-term debt, current	-	-	998	-	998
Total current liabilities	308	171	1,167	161	1,254
Long-term debt, non-current	5,817	7,096	6,119	6,135	6,615
Total non-current liabilities	5,817	7,096	6,121	6,136	6,627
Total liabilities	6,124	7,267	7,288	6,298	7,880
Common stock and paid-in capital	2,866	3,508	3,666	4,011	4,103
Retained earnings	1,921	2,255	1,965	2,518	2,846
Stockholders' equity	9,896	10,249	9,525	10,084	10,342
Total debt	5,817	7,096	7,116	6,135	7,612
Net debt	4,738	5,489	5,404	5,640	6,625
D/E ratio (%)	58.8	69.2	74.7	60.8	73.6